A compendium of the major classes of drugs, this invaluable, clinical guide to the pharmacology of psychiatric disorders includes graphs and tables illustrating drug effects and treatment results. Each drug is given a brief description-including controversies, side-effects, and uses-and is listed in alphabetical order within six major categories authorized by recognized experts in their fields: * Stimulants, Arthur Rifkin, M.D.* Antidepressants, Frederic M. Quitkin, M.D., Bonnie P. Taylor, M.A.* Antimanic Agents, Charles L. Bowden, M.D.* Sedative-Hypnotics, Eric J. Heyer, M.D., Ph.D., David C. Adams, M.D.* Antipsychotic Agents, Rajiv Tandon, M.D.* Antianxiety Agents: Benzodiazepine Derivatives, Edward M. Sellers, M.D., Ph. D., F.R.C.P.C.

Published in 1996, Current Psychotherapeutic Drugs is a valuable contribution to the field of Psychotherapy.

This book has been written forpracticing physicians, psychiatristsand students who wish tolearn how better to use drugs inthe treatment of patients withemotional disorders. Clinical experiencewith these drugs is relatedto their pharmacologicalproperties that bear most directlyontheir application to thetreatment of emotional disordersin man.

Summarizes the extent of drug abuse in the U.,S., its health implications, and recent advances in the prevention and treatment of drug dependence. Sections include: the nature and extent of drug abuse in the U.S.; prevention research; treatment research; dual diagnosis: drug abuse and psychiatric illness; AIDS and intravenous drug abuse; cocaine and other stimulants; marijuana and the cannabinoids; phencyclidine (PCP) and related substances; heroin, other opiates, and the immune function; sedatives and anti-anxiety agents; nicotine dependence; and basic research on opioid peptides and receptors.

Emerging Cognitive Neuroscience and Related Technologies, from the National Research Council, identifies and explores several specific research areas that have implications for U.S. national security, and should therefore be monitored consistently by the intelligence community. These areas include: neurophysiological advances in detecting and measuring indicators of psychological states and intentions of individuals the development of drugs or technologies that can alter human physical or cognitive abilities advances in real-time brain imaging breakthroughs in high-performance computing and neuronal modeling that could allow researchers to develop systems which mimic functions of the human brain, particularly the ability to organize disparate forms of data. As these fields continue to grow, it will be imperative that the intelligence community be able to identify scientific advances relevant to national security when they occur. To do so will require adequate funding, intelligence analysts with advanced training in science and technology, and increased collaboration with the scientific community, particularly academia. A key tool for the intelligence community, this book will also be a useful resource for the health industry, the military, and others with a vested interest in technologies such as brain imaging and cognitive or physical enhancers.